Edition:
United States

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

107.84USD
3:59pm EST
Change (% chg)

$0.29 (+0.27%)
Prev Close
$107.55
Open
$109.44
Day's High
$111.69
Day's Low
$106.05
Volume
129,742
Avg. Vol
131,895
52-wk High
$195.97
52-wk Low
$100.20

Select another date:

Fri, Nov 2 2018

FDA panel recommends Sage's postpartum depression treatment

An advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc's experimental treatment for postpartum depression, saying the benefits of the drug outweighed risks.

UPDATE 2-FDA panel recommends Sage's postpartum depression treatment

Nov 2 An advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc's experimental treatment for postpartum depression, saying the benefits of the drug outweighed risks.

Sage's postpartum depression treatment benefits outweigh risk: FDA panel

Nov 2 The benefits of Sage Therapeutics Inc's experimental treatment for postpartum depression outweigh risks, an advisory panel to the U.S. Food and Drug Administration said on Friday.

Select another date: